Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Eotaxin-3 (CCL26)

Eotaxin-3 is a CC chemokine that signals through the CCR3 receptor. It is produced by endothelial cells stimulated with IL-4 or IL-13. Eotaxin-3 selectively targets cells expressing CCR3, including eosinophils, basophils, T cells and monocytes. Eotaxin-3 has similar activity to Eotaxin and Eotaxin-2, but the three Eotaxins share only a low degree of sequence homology. Recombinant human Eotaxin-3 is an 8.4 kDa protein containing 71 amino acid residues, including the four highly conserved cysteine residues present in CC chemokines.

Product Specifications

Synonyms

CCL26; IMAC; TSC-1; MIP-4a; SCYA26; MIP-4alpha

NCBI Gene ID

10344

UniProt

Q9Y258

Accession Number

NP_006063

Accession Number mRNA

NM_006072

Chromosomal Location

7q11.23

Reactivity

Human

Cross Reactivity

Human

Sequence

TRGSDISKTC CFQYSHKPLP WTWVRSYEFT SNSCSQRAVI FTTKRGKKVC THPRKKWVQK YISLLKTPKQ L

Endotoxin

< 0.1 ng/µg of protein (< 1EU/µg)

Purity

> 98% by SDS-PAGE & HPLC analyses

Bioactivity

Determined by its ability to chemoattract human CCR3/HEK 293 cells. The maximum activity was achieved at 2 µg/ml.

Length

71

Form

Lyophilized

Molecular Weight

8.4 kDa

Host or Source

E. coli

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Anti-RABL2A Antibody
MBS8241754-01 0.03 mL

Anti-RABL2A Antibody

Sign In for Pricing
View Details
Anti-RABL2A Antibody
MBS8241754-02 0.05 mL

Anti-RABL2A Antibody

Sign In for Pricing
View Details
Anti-RABL2A Antibody
MBS8241754-03 0.1 mL

Anti-RABL2A Antibody

Sign In for Pricing
View Details
Anti-RABL2A Antibody
MBS8241754-04 0.2 mL

Anti-RABL2A Antibody

Sign In for Pricing
View Details
Anti-RABL2A Antibody
MBS8241754-05 5x 0.2 mL

Anti-RABL2A Antibody

Sign In for Pricing
View Details
Human FBXO16 Pre-designed siRNA Set B
SI005536B 1 Each

Human FBXO16 Pre-designed siRNA Set B

Sign In for Pricing
View Details